Susanne Grether-Beck

Dr. Susanne Grether-Beck


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2014 in Photodermatology, Photoimmunology & Photomedicine
Verified
Journal Article
Open access
PDF file
SGSusanne Grether-Beck
Susanne Grether-Beck
AMAlessandra Marini
Alessandra Marini
TJThomas Jaenicke
Thomas Jaenicke
JKJean Krutmann
Jean Krutmann
Summary: Photoprotection of human skin by means of sunscreens or daily skin‐care products is traditionally centered around the prevention of acute (e.g. sunburn) and chronic (e.g. skin cancer and photoaging) skin damage that may result from exposure to ultraviolet rays (UVB and UVA). Within the last decade, however, it has been appreciated that wavelengths beyond the ultraviolet spectrum, in particular visible light and infrared radiation, contribute to skin damage in general and photoaging of human skin in particular. As a consequence, attempts have been made to develop skin care/sunscreen products that not only protect against UVB or UVA radiation but provide photoprotection against visible light and infrared radiation as well. In this article, we will briefly review the current knowledge about the mechanisms responsible for visible light/infrared radiation‐induced skin damage and then, based on this information, discuss strategies that have been successfully used or may be employed in the future to achieve photoprotection of human skin beyond ultraviolet radiation. In this regard we will particularly focus on the use of topical antioxidants and the challenges that result from the task of showing their efficacy.

15 May 2021 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
SGSusanne Grether-Beck
Susanne Grether-Beck
IFI. Felsner
I. Felsner
HBH. Brenden
H. Brenden
AMA. Marini
A. Marini
TJT. Jaenicke
T. Jaenicke
JKJean Krutmann
Jean Krutmann
Background Melanism is more frequent in animals living in polluted areas at urban-industrial sites. Given that a growing part of the human population is exposed to elevated air pollution levels, we wondered if environmental pollutants might affect melanogenesis in human skin likewise. Epidemiological studies in Caucasians and East Asians indeed showed that exposure to traffic-related air pollutants such as Diesel Exhaust Particles (DEP) is associated with more clinical signs of hyperpigmentation. Mechanistic evidence linking DEP exposure with pigmentation, however, has been elusive. Objectives to develop an ex vivo skin model allowing topical repetitive application of ambient relevant DEP and proof-of-concept in humans. Methods Measurement of skin pigmentation, melanin and pigmentation associated gene expression and evaluation of oxidative stress. Results Repetitive exposure of ex vivo skin to DEP at non-toxic concentrations increased pigmentation. This increase was visible by the naked eye, time-dependent, associated with an increase in melanin content and transcription of genes involved in melanin de novo synthesis. In healthy subjects (n=76) repetitive topical application of DEP at non-toxic concentrations increased skin pigmentation similarly. DEP-induced pigmentation was mediated by an oxidative stress response, because after DEP application (i) epidermal antioxidants were depleted, (ii) lipid peroxidation and oxidative DNA damage were enhanced, and (iii) in a vehicle-controlled, double-blinded, clinical study DEP-induced pigmentation was prevented by topical application of an antioxidant mixture. Conclusion Similar to solar radiation, air pollutants cause skin tanning. Since eumelanin is an antioxidant, we propose that this response serves to protect human skin against air pollution-induced oxidative stress.

31 March 2021 in Skin Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
HZHua Zhao
Hua Zhao
JWJinhao Wu
Jinhao Wu
NWNan Wang
Nan Wang
SGSusanne Grether-Beck
Susanne Grether-Beck
JKJean Krutmann
Jean Krutmann
LWLiu Wei
Liu Wei
Background: Oral supplementation with a standardized extract from the bark of the French pine (Pycnogenol®) has been reported to benefit the skin. It might thus represent an easy-to-use strategy to improve the skin health of individuals who are exposed to considerable environmental stress in large urban areas. Objective: We investigated if oral intake of Pycnogenol® can benefit the skin of Han Chinese working outdoors in Beijing, China. Methods: In a monocentre, double-blind, randomized, placebo-controlled, and crossover study, the effects of Pycnogenol® intake (2 × 50 mg/day for a total of 12 weeks) on a variety of skin physiological parameters was studied in Chinese subjects (n = 76), from spring to autumn, who were working outdoors in Beijing, China. Results: During the intervention period, study subjects were constantly exposed to increased levels of particulate matter (PM)2.5 as well as seasonal changes in humidity and temperature. Despite this environmental stress, Pycnogenol® intake prevented (i) a decrease in the skin hydration, (ii) transepidermal water loss (TEWL), and (iii) skin darkening during the dry autumn season. In addition, Pycnogenol® intake improved (iv) viscoelastic skin properties such as gross elasticity and elastic recovery irrespective of the season. These beneficial effects were not observed if the same subjects were supplemented with placebo. Conclusion: Oral intake of Pycnogenol® benefits the skin in Han Chinese, who are working outdoors under considerable environmental stress.

12 February 2022 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
JNJuliane Rocio Neves
Juliane Rocio Neves
SGSusanne Grether-Beck
Susanne Grether-Beck
JKJean Krutmann
Jean Krutmann
PCPriscila Correia
Priscila Correia
JGJosé Euzébio Gonçalves
José Euzébio Gonçalves
DKDelphine Kerob
Delphine Kerob

21 December 2022 in Allergy
Verified
Journal Article
Open access
CVChristian Vogeley
Christian Vogeley
SKSara Kress
Sara Kress
DLDieter Lang
Dieter Lang
CVChristoph F. A. Vogel
Christoph F. A. Vogel
FHFrederick Hartung
Frederick Hartung
Thomas Haarmann-StemmannThomas Haarmann-Stemmann
Thomas Haarmann-Stemmann

6 January 2023 in Health Science Reports
Verified
Journal Article
Open access
CCCarr Cai
Carr Cai
BZBill Zeng
Bill Zeng
LLLydia Lin
Lydia Lin
MZMiranda Zheng
Miranda Zheng
CBCarolina Burki
Carolina Burki
JKJean Krutmann
Jean Krutmann
Background and Aims: Female pattern hair loss affects females of all ages with a trend to increase after menopause. This disorder may have significant psychological impact and lead to anxiety and depression.Objective: In a single center, double blind, randomized, placebo‐controlled study, the effects of oral Pycnogenol® intake (3 × 50 mg/day for a total of 6 months) on hair density, scalp microcirculation, and a variety of skin physiological parameters was studied in Han Chinese menopausal women (N = 76) in Shanghai, China.Methods: Measurements were taken at the beginning and after 2 and 6 months, respectively. Hair density was determined by digital photographs and further evaluated by Trichoscan software. Transepidermal water loss was measured by a humidity sensor in a closed chamber on the skin surface. Changes in microcirculation were detected as resting flux on the scalp by reflection photoplethysmography.Results: Pycnogenol® intake significantly increased hair density by 30% and 23% after 2 and 6 months of treatment, respectively, as detected by Trichoscan® evaluation of digital photographs. Interestingly, photoplethysmography revealed that this beneficial effect was associated with a decrease in resting flux of the scalp skin, which might indicate an improvement of microcirculation. None of these effects were observed in the placebo taking group. In addition, a significant transient decrease of transepidermal water loss was observed in scalp skin under Pycnogenol,® but not placebo treatment.Conclusion: Oral intake of Pycnogenol® might have the potential to reduce hair loss in postmenopausal women.